Skip to main content
Gynecologic Oncology Reports logoLink to Gynecologic Oncology Reports
. 2021 Jan 21;35:100704. doi: 10.1016/j.gore.2021.100704

Erratum regarding missing Declaration of Competing Interest statements in previously published articles

PMCID: PMC7878929  PMID: 33614878

Declaration of Competing Interest statements were not included in the published version of the following articles that appeared in previous issues of Gynecologic Oncology Reports GORE.

The appropriate Declaration/Competing Interest statements, provided by the Authors, are included below.

  • 1.

    “Laparoscopic diverting loop ileostomy for spontaneous colon perforation in advanced ovarian cancer” (Gynecologic Oncology Reports, 28: 84–85) https://doi.org/10.1016/j.gore.2019.03.003

  • Declaration of Competing Interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

  • 2.

    “Pazopanib treatment of a platinum-resistant recurrence of a high-grade Sertoli cell tumor and assessment of the treatment response by FDG-PET/CT: A case report” (Gynecologic Oncology Reports, 24: 54–56) https://doi.org/10.1016/j.gore.2018.03.002

  • Declaration of Competing Interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

  • 3.

    “Müllerian carcinosarcoma arising from atypical pelvic endometriosis” (Gynecologic Oncology Reports, 25: 87–89) https://doi.org/10.1016/j.gore.2018.06.009

  • Declaration of Competing Interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

  • 4.

    “Two cases of spindle cell variant diffuse large B-cell lymphoma of the uterine cervix” (Gynecologic Oncology Reports, 33: 100611) https://doi.org/10.1016/j.gore.2020.100611

  • Declaration of Competing Interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

  • 5.

    “Mucinous adenocarcinoma of the endometrium with metastasis to the clitoral glans after pelvic exenteration for radiation resistant vaginal cuff recurrence” (Gynecologic Oncology Reports, 27: 46–49) https://doi.org/10.1016/j.gore.2018.12.003

  • Declaration of Competing Interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

  • 6.

    “The dilemma of early preventive oophorectomy in familial small cell carcinoma of the ovary of hypercalcemic type” (Gynecologic Oncology Reports, 28: 47–49) https://doi.org/10.1016/j.gore.2019.02.002

  • Declaration of Competing Interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

  • 7.

    “Treatment of cervical cancer metastatic to the abdominal wall with reconstruction using a composite myocutaneous flap: A case report” (Gynecologic Oncology Reports, 27: 38–41) https://doi.org/10.1016/j.gore.2018.12.006

  • Declaration of Competing Interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

  • 8.

    “Management of acute haemorrhage following chemotherapy for invasive molar pregnancy by embolization and conservative fertility-sparing surgery” (Gynecologic Oncology Reports, 32: 100556) https://doi.org/10.1016/j.gore.2020.100556

  • Declaration of Competing Interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

  • 9.

    “NTRK-1 fusion in endocervical fibroblastic malignant peripheral nerve sheath tumor marking eligibility for larotrectinib therapy: A case report” (Gynecologic Oncology Reports, 28: 141–144) https://doi.org/10.1016/j.gore.2019.04.006

  • Declaration of Competing Interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

  • 10.

    “A case of ovarian endometrioid adenocarcinoma with yolk sac differentiation and Lynch syndrome” (Gynecologic Oncology Reports, 27: 60–64) https://doi.org/10.1016/j.gore.2019.01.001

  • Declaration of Competing Interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

  • 11.

    “Multiple recurrences from cervical cancer presenting as skin metastasis of different morphologies” (Gynecologic Oncology Reports, 28: 61–64) https://doi.org/10.1016/j.gore.2019.02.008

  • Declaration of Competing Interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

  • 12.

    “Pilot study of a condensed communication skills workshop for gynecologic oncology fellows” (Gynecologic Oncology Reports, 30: 100492) https://doi.org/10.1016/j.gore.2019.100492

  • Declaration of Competing Interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.


Articles from Gynecologic Oncology Reports are provided here courtesy of Elsevier

RESOURCES